CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the 29th
Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2011
at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time at The Westin St.
Francis in San Francisco. The presentation will be followed by a
question and answer session that will begin at approximately 11:30 a.m.
Pacific Time / 2:30 p.m. Eastern Time.
A live webcast of both the presentation and the question and answer
session will be accessible through the Investors section of Ironwood's
website at www.ironwoodpharma.com.
To access the webcasts, please log on to the Ironwood website
approximately 15 minutes prior to the start time to ensure adequate time
for any software downloads that may be required. A replay of each
webcast will be available on Ironwood's website for 14 days following
the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC‐C agonist, is being evaluated in
a confirmatory Phase 3 program for the treatment of irritable bowel
syndrome with constipation (IBS‐C) and chronic constipation. Ironwood
also has a growing pipeline of additional drug candidates in earlier
stages of development. Ironwood is located in Cambridge, Mass. To learn
more, visit www.ironwoodpharma.com.
Ironwood Pharmaceuticals, Inc.
Susan Brady, 617-621-8304
Corporate
Communications
sbrady@ironwoodpharma.com
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media